
NIST AI Risk Management Framework 1.0 2023 Is Becoming Pharma’s Blueprint for Safe, Scalable AI
Most pharma teams are still trying to force AI into 20‑year‑old GxP processes — but the playbook they need already exists, and it didn’t come from EMA or FDA.